HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete remission of metastasized adrenocortical carcinoma under o,p'-DDD.

Abstract
The case of a 53 year old female patient with metastasized androgen producing adrenocortical carcinoma is presented. After initial adrenalectomy a local relapse had been treated by surgery and external irradiation. Solitary liver metastases had been resected repeatedly. Subsequently multiple liver metastases required systemic chemotherapy. Treatment with o,p'-DDD (initially 12 g/d, long term treatment 1.5-3 g/d) has resulted in a complete remission for nearly 4 years. Gastrointestinal side effects occurred initially but subsided with dose reduction of o,p'-DDD.
AuthorsE Kornely, R Schlaghecke
JournalExperimental and clinical endocrinology (Exp Clin Endocrinol) Vol. 102 Issue 1 Pg. 50-3 ( 1994) ISSN: 0232-7384 [Print] Germany
PMID8005209 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Mitotane
Topics
  • Adrenal Cortex Neoplasms (drug therapy, radiotherapy, surgery)
  • Adrenalectomy
  • Female
  • Humans
  • Liver Neoplasms (drug therapy, secondary)
  • Middle Aged
  • Mitotane (administration & dosage, adverse effects, therapeutic use)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: